Delivery Order SPE2DB20D1100-SPE2DB25FB9W3
Award Date
4/28/25
Potential Completion Date
4/29/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Cosentyx (Secukinumab) 300mg dose injector pens, a specialty biologic medication used to treat certain autoimmune conditions. The fixed-price contract has a ceiling value of $9,165.29 and a completion date of August 6, 2024. This order is likely part of a larger Indefinite...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,262.83 firm-fixed-price contract is for the supply of Cosentyx (secukinumab) 300mg dose autoinjectors. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides global pharmaceutical support services to military healthcare programs. The contract is...
This federal contract award, valued at $15,236.75, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cosentyx (secukinumab) 150 mg/mL injectable pens, a medication used to treat various autoimmune conditions. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, and has an ultimate completion date of April...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Cosentyx (secukinumab) 300 mg doses, a medication used to treat various autoimmune conditions. The contract has a ceiling value of $5,083.65 and a period of performance through April 23, 2025. It is a firm-fixed-price, non-set-aside contract, indicating open competition. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,350.74, is for the delivery of Cosentyx (Secukinumab) 300 mg Pen injectors. This is a Firm Fixed Price Delivery Order contract with a completion date of December 11, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx Sensoready 150 mg pens, a medication used to treat certain autoimmune conditions. The contract has a ceiling value of $10,074.45 and is a firm fixed-price, non-set-aside contract with an ultimate completion date of April 22, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,494.92 firm fixed-price contract is for the supply of Cosentyx (secukinumab) 300 mg pens, a biologic medication used to treat various autoimmune conditions. The contract has an ultimate completion date of April 2, 2025 and was awarded on April 1, 2025. This delivery order is part of a larger Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,238.13 firm fixed-price contract is to deliver the medication Cosentyx (secukinumab) 300mg dose-2 pen, which is used to treat certain autoimmune conditions. The contract has a period of performance through September 27, 2023. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp., a large pharmaceutical distributor, for the supply of Cosentyx (secukinumab) 300mg dose-2 pen injectors. The $10,653.65 firm fixed-price contract does not have a set-aside designation and has an ultimate completion date of August 1, 2024. As a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, AmerisourceBergen holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Cosentyx (secukinumab) 300 mg dosage pens, a specialty medication used for various medical conditions. The contract has a ceiling value of $21,495.87 and runs through June 27, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen...